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Background
Using mouse models we reported that dendritic cells
(DC) pulsed with cancer stem cells (CSC) enriched by
virtue of their expression of the CSC marker aldehyde
dehydrogenase (ALDH) significantly reduced develop-
ment of pulmonary metastases and prolonged survival.
In this recent study, we established the concept that the
antigenicity/immunogenicity of ALDHhigh human head
and neck squamous cell carcinoma (HNSCC) cancer
stem cells is distinct from that of ALDHlow non-CSCs.
Methods
Patients with HNSCC enrolled in the University of
Michigan Special Project of Research Excellence
(SPORE) were recruited to collect tumor and peripheral
blood samples. T or B cells were purified from the
PBMCs using anti-CD3-coupled or anti-CD19-coupled
microbeads respectively with a MACS separator. Primary
tumor samples were digested and collected. ALDE-
FLUOR+/ALDHhigh or ALDEFLUOR-/ALDHlow cells
were isolated from tumor cells. ALDHlow lysate-pulsed
DCs (ALDHlow -DC) or ALDHhigh lysate-pulsed DCs
(ALDHhigh-DC, e.g. CSC-DC) were used as vaccines. To
detect T and B cells in PBMCs, PBMCs were stained
with PerCP mouse anti-human CD3 and FITC mouse
anti-human CD19. Before sensitization in vitro, T or
B cells were activated respectively with immobilized anti-
human CD3 and anti-human CD28 in complete medium
(CM) containing hrIL-2 or lipopolysaccharide plus anti-
human CD45. Statistical analyses were performed to
compare various interactions of the DC vaccine-primed/
sensitized T, B cells with autologous ALDHhigh CSC vs.
ALDHlow HNSCC target cells.
Results
DCs generated from the PBMC and pulsed with the lysate
of ALDHhigh cells isolated from cultured HNSCC cells
(CSC-DC) could sensitize autologous T, B lymphocytes in
vitro, which was evident by cytokine production, CTL activ-
ity, and antibody secretion of these primed T, B cells in
response to ALDHhigh CSCs. In contrast, DCs pulsed with
lysate of ALDHlow cells from the same HNSCC patient
(ALDHlow-DC) resulted in limited sensitization/priming of
autologous T, B lymphocytes to produce IFNg, lyse CSCs,
and secrete IgM and IgG in response to ALDHhigh CSCs.
Conclusions
These results demonstrated significant differences in the
antigenicity/immunogenicity between ALDHhigh CSCs
vs. ALDHlow cells isolated from the tumor specimen of
patients with HNSCC, which indicates the existence of
unique CSC antigens in the ALDHhigh population. In
addition, this study demonstrates that it is feasible to
generate DCs from the PBMCs and isolate ALDHhigh
CSCs from tumor cells of the patients with HNSCC to
prepare CSC-DC vaccines for clinical application.
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